← back to search

Christiane Jungels

Institut Jules Bordet ·
Area of research
Oncology · Biotechnology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Cancer Research and Treatments, Immunotherapy and Immune Responses, and CAR-T cell therapy research.
h-index
17
citations
2,795
works
86
NIH funding
primary concept
Medicine
email

Recent publications

Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
Annals of Oncology 2021cited by 955position: middledoi
Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology 2021cited by 550position: middledoi
Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up
Annals of Oncology 2021cited by 439position: middledoi
Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts
ESMO Open 2021cited by 179position: middledoi
A phase I/II study of safety and efficacy of the arginase inhibitor INCB001158 plus chemotherapy in patients (Pts) with advanced biliary tract cancers.
Journal of Clinical Oncology 2021cited by 32position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Lulu Cheng · Guangzhou University of Chinese Medicine1 papers (2021–2021)Jean-Luc Canon · Institute of Pathology and Genetics1 papers (2021–2021)Aung Naing · The University of Texas MD Anderson Cancer Center1 papers (2021–2021)Fiona Thistlethwaite · University of Manchester1 papers (2021–2021)Kyriakos P. Papadopoulos · Texas Center for Infectious Disease1 papers (2021–2021) · 1 papers (2021–2021)Olumide B. Gbolahan · Emory University1 papers (2021–2021)Milind Javle · The University of Texas MD Anderson Cancer Center1 papers (2021–2021) · 1 papers (2021–2021)John Bridgewater · University College Hospital1 papers (2021–2021)Sven Gogov · Novartis (Switzerland)1 papers (2021–2021)